OliX Pharmaceuticals seeks FDA nod for phase 2a trial of OLX10010

OliX Pharmaceuticals, a South Korean pharma company, has submitted an investigational new drug (IND) application to the US Food and Drug Administration (FDA) seeking its ... Read More